Chemotherapy Plus EGFR Monoclonal Antibody in Patients With Liver Metastases From Colorectal Cancer With ctDNA Superselective Negative Genes

NCT06490913 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

33

Enrollment

OTHER_GOV

Sponsor class

Conditions

Liver Metastases of Colorectal Cancer

Interventions

DRUG: Capecitabine
DRUG: oxaliplatin
DRUG: Cetuximab
DRUG: Oxaliplatin
DRUG: Leucovorin
DRUG: 5-FU

Sponsor

Fujian Cancer Hospital